Cap Nimodipine in the Treatment of Cerebrovascular Disease:A Double-Blind Placebo-Controlled Trial / 中国医师杂志
Journal of Chinese Physician
;
(12)2001.
Artigo
em Chinês
| WPRIM
| ID: wpr-519030
ABSTRACT
Objective To study the effect of Cap Nimodipine on the treatment of three kinds of cerebrovascular disease included acute ischemic cerebrovascular disease(AICVD),subarachroid hemorrahage(SAH),and multiple infarct dementia(MID).Method 103 cases were orally given cap nimodipine 30mg tid/d ,for 18 monthes. The efficacy was assessed by a double-blind placebo-controlled trial.Results ⑴ AICVD treating group comparing to placebo group, there was significant difference in effective rate,(P0 1).⑵SAH treating group compared with placebo group,we revealed that the cerebrovascular system (CVS) event rate and death rate decreased markedly (P
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Tipo de estudo:
Ensaio Clínico Controlado
Idioma:
Chinês
Revista:
Journal of Chinese Physician
Ano de publicação:
2001
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS